Cause-Specific Mortality in Male US Veterans with Rheumatoid Arthritis

Arthritis Care and Research

Volumn 68, Issue 1, 2016, Pages 36-45

  England, Bryant R ^a   Sayles, Harlan ^a   Michaud, Kaleb ^a,b   Caplan, Liron ^c   Davis, Lisa A ^c   Cannon, Grant W ^d   Sauer, Brian C ^d   Solow, Elizabeth B ^e   Reimold, Andreas M ^e   Kerr, Gail S ^f   Schwab, Pascale ^g   Baker, Josh F ^h   Mikuls, Ted R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f HOWARD UNIVERSITY   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; ANTIRHEUMATIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CAUCASIAN; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; DISEASE ACTIVITY; DRUG USE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; RHEUMATOID ARTHRITIS; SMOKING; SURVIVAL RATE; VETERAN; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; LIFESTYLE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TIME FACTOR; UNITED STATES; VERY ELDERLY; VETERANS HEALTH;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESPIRATORY TRACT DISEASES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; UNITED STATES; VETERANS HEALTH;

EID: 84956686279     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22642     Document Type: Article

References (39)

1. Sokka T, Abelson B, Pincus T., Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26: S35-61.
2. Humphreys JH, Warner A, Chipping J, Marshall T, Lunt M, Symmons DP, et al., Mortality trends in patients with early rheumatoid arthritis over 20 years: Results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2014; 66: 1296-301.
3. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM III, Therneau TM, et al., The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-7.
4. Mikuls TR, Fay BT, Michaud K, Sayles H, Thiele GM, Caplan L, et al., Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: Results from the VARA registry. Rheumatology (Oxford) 2011; 50: 101-9.
5. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A., High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
6. Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, et al., Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009; 61: 1571-9.
7. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al., Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
8. Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S., Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset. J Rheumatol 1999; 26: 2562-71.
9. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR., Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997; 24: 445-51.
10. Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP., Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002; 46: 2010-9.
11. Smitten AL, Simon TA, Hochberg MC, Suissa S., A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10: R45.
12. Franklin J, Lunt M, Bunn D, Symmons D, Silman A., Influence of inflammatory polyarthritis on cancer incidence and survival: Results from a community-based prospective study. Arthritis Rheum 2007; 56: 790-8.
13. Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L, et al., Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south European population. Semin Arthritis Rheum 2008; 37: 388-97.
14. Llorca J, Lopez-Diaz MJ, Gonzalez-Juanatey C, Ollier WE, Martin J, Gonzalez-Gay MA., Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. Semin Arthritis Rheum 2007; 37: 31-8.
15. Weyand CM, Schmidt D, Wagner U, Goronzy JJ., The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 1998; 41: 817-22.
16. Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, et al., Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum 2010; 62: 1583-91.
17. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM III, Therneau TM, et al., Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008; 35: 1009-14.
18. Lee TA, Shields AE, Vogeli C, Gibson TB, Woong-Sohn M, Marder WD, et al., Mortality rate in veterans with multiple chronic conditions. J Gen Intern Med 2007; 22 Suppl 3: 403-7.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
20. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP., Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346-53.
21. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
22. Pincus T, Swearingen CJ, Bergman M, Yazici Y., RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: Proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 2008; 35: 2136-47.
23. Miriovsky BJ, Michaud K, Thiele GM, O'Dell JR, Cannon GW, Kerr G, et al., Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1292-7.
24. Mikuls TR, Gould KA, Bynote KK, Yu F, Levan TD, Thiele GM, et al., Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: Influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study. Arthritis Res Ther 2010; 12: R213.
25. England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K., Validation of the Rheumatic Disease Comorbidity Index. Arthritis Care Res (Hoboken) 2015; 67: 865-72.
26. Andersen PK, Geskus RB, de Witte T, Putter H., Competing risks in epidemiology: Possibilities and pitfalls. Int J Epidemiol 2012; 41: 861-70.
27. Wolfe F, Michaud K., Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1471-9.
28. Michaud K, Wolfe F., The development of a rheumatic disease research comorbidity index for use in outpatients with RA, OA, SLE, and fibromyalgia (FMS) [abstract]. Arthritis Rheum 2007; 56 Suppl: S596.
29. Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM., Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum 2013; 65: 334-42.
30. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F., Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study. Lancet 2002; 359: 1173-7.
31. Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P, et al., Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70: 576-82.
32. Lunt M, Watson KD, Dixon WG, British Society for Rheumatology Biologics Register Control Centre Consortium, Symmons DP, Hyrich KL, et al., No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2010; 62: 3145-53.
33. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al., The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
34. Kuller LH, Mackey RH, Walitt BT, Deane KD, Holers VM, Robinson WH, et al., Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis. Arthritis Rheum 2014; 66: 497-507.
35. Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, et al., Incidence and mortality of obstructive lung disease in rheumatoid arthritis: A population-based study. Arthritis Care Res (Hoboken) 2013; 65: 1243-50.
36. Sparks J, Chang S, Liao K, Lu B, Solomon D, Costenbader K, et al., Incident rheumatoid arthritis and risk of mortality among women followed prospectively from 1976 to 2010 in the nurses' health study [abstract]. Presented at the American College of Rheumatology Annual Meeting; November 14-19, 2014; Boston (MA).
37. Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, et al., Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: Results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007; 56: 1408-16.
38. Longo WE, Cheadle W, Fink A, Kozol R, DePalma R, Rege R, et al., The role of the Veterans Affairs medical centers in patient care, surgical education, research and faculty development. Am J Surg 2005; 190: 662-75.
39. Boyle C, Decoufle P., National sources of vital status information: Extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990; 131: 160-8.